Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
Is GSK an Excellent Dividend Stock to Buy for Passive Income Investors?
04:21pm, Monday, 14'th Aug 2023
GSK offers a robust dividend yield, but that's not the only thing to consider.
3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
08:39am, Monday, 14'th Aug 2023
We look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings estimates.
3 Pharma Stocks to Sell in August Before They Crash and Burn
08:52pm, Friday, 11'th Aug 2023
With pharmaceutical companies, it's all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future presc
Dividend Income Update July 2023
11:24am, Monday, 07'th Aug 2023
July was exciting as ever as my year-over-year numbers continue to highlight the trifecta magic of dividend investing, which includes adding fresh capital, dividend raises and basic compounding to cre
Pfizer Sued By GSK Over Alleged Patent Infringement For Its RSV Vaccine
02:02pm, Wednesday, 02'nd Aug 2023
British drugmaker GlaxoSmithKline is accusing Pfizer of infringing on four of its patents in its RSV vaccine.
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine
10:59am, Wednesday, 02'nd Aug 2023
Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
GSK sues Pfizer in US for patent infringement over RSV vaccine
09:34am, Wednesday, 02'nd Aug 2023
British biopharmaceutical giant GSK sued Pfizer in Delaware federal court on Wednesday, accusing Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo of violating GSK's patent rights in its riva
If You Can Only Buy One Dividend Stock, It Better Be One of These 7 Names
03:11pm, Sunday, 30'th Jul 2023
It's nice to own stocks that are well-positioned to rally and pay you for waiting for them to do so. That's especially true for older investors who want to buy stocks, and generate income.
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
03:00pm, Sunday, 30'th Jul 2023
The pharmaceutical sector generates a huge $1.2 trillion of revenue globally, and the U.S. is by far the most lucrative country for drug makers in the world. Therefore, the profits of successful Ameri
Is GSK Stock Worth Buying Right Now?
07:30pm, Saturday, 29'th Jul 2023
British drugmaker GSK has been in reorganization mode since 2017. The new GSK should sport higher growth, profitability, and increased productivity.
GSK Beats on Q2 Earnings & Sales, Raises 2023 Guidance
12:25pm, Wednesday, 26'th Jul 2023
GSK's revenues benefit from strong growth across all segments, especially HIV and vaccine. GSK raises guidance for earnings and sales.
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
12:11pm, Wednesday, 26'th Jul 2023
London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall, when the disease begins to spread at higher levels.
GSK (GSK) Surpasses Q2 Earnings and Revenue Estimates
08:40am, Wednesday, 26'th Jul 2023
GSK (GSK) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.87 per share a year ago.
India's GlaxoSmithKline Pharma posts rise in Q1 profit on steady vaccine business
08:21am, Wednesday, 26'th Jul 2023
GlaxoSmithKline Pharmaceuticals , the Indian unit of UK's GSK plc , posted an 11% rise in first-quarter profit on Wednesday, buoyed by strong demand for its vaccines.
GSK expects RSV vaccine uptake will be slower than for its shingles vaccine-CEO
05:32am, Wednesday, 26'th Jul 2023
GSK does not expect uptake of its RSV vaccine will initially be as swift as it was for its blockbuster shingles vaccine, though the company is confident in its new inoculation, Chief Executive Emma Wa
